The importance of re-evaluation in patients with cystitis glandularis associated with pelvic lipomatosis: a case report


Sozen S., Gurocak S., Uzum N., Biri H., Memis L., Bozkirli I.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, vol.22, no.5, pp.428-430, 2004 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 5
  • Publication Date: 2004
  • Doi Number: 10.1016/j.urolonc.2004.04.034
  • Journal Name: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.428-430
  • Keywords: bladder, cystitis glandularis, pelvic lipomatosis, aadenocarcinoma, neoplasm, ADENOCARCINOMA, BLADDER
  • Gazi University Affiliated: No

Abstract

Pelvic lipomatosis is a rare, proliferative disease involving an overgrowth of normal fat in the pelvic retroperitoneal space. Cystitis glandularis, cystitis cystica, or cystitis follicularis can be observed in 75% of patients with pelvic lipomatosis. We describe a 58-yr-old man with pelvic lipomatosis in whom adenocarcinoma of the bladder was diagnosed in the second transurethral resection of the bladder 1 month after the first operation. This proliferative disease can cause obstruction of the bladder drainage leading to a proliferative cystitis because of an altered environment rich in protein fluid. Because the association of this proliferative disease with adenocarcinoma of the bladder is frequent, we recommend close follow-up of these patients to detect the associated adenocarcinoma of the bladder. (C) 2004 Elsevier Inc. All rights reserved.